Milk Ingredients and Resistance Against E-coli-induced GastroEnteritis (MIRAGE)
NCT01800396
Bacterial Infection, Bacterial Infections
Ede, Netherlands
View Trial DetailsNCT Number: NCT00915213
The purpose of this study is to discover how often certain bacteria are found in the rectum at the time of a prostate needle biopsy to diagnose prostate cancer. Certain bacteria are of importance because they can cause serious infection. Antibiotics that urologists commonly use to prevent these bacteria from causing infection are no longer effective. Many physicians around the world are noting increased infections with antibiotic resistant bacteria. Therefore; despite treating patients who are to undergo prostate biopsy with antibiotics, certain patients are being readmitted to the hospital with a serious infection. In order to study the incidence of these particular bacteria, the best method is to culture the bacteria at the time of the biopsy. This involves one rectal culture swab just prior to needle biopsy of the prostate. Once the incidence of these bacteria is known we may take steps to prevent the serious infections that occur as a result of prostate biopsy.
Looking for future studies?
Notify Me18 year and older
Male
Observational
Kaiser Permanente, Irvine, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University of California, Irvine
Other
Incidence of Fluoroquinolone Resistant Enterobacteraciae in Patients Undergoing Repeat Ultrasound Guided Prostate Biopsy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01800396
Bacterial Infection, Bacterial Infections
Ede, Netherlands
View Trial DetailsNCT01225042
Bacterial Infection, Bacterial Infections
Ede, Netherlands
View Trial DetailsNCT06709521
Bacterial Infection, Bacterial Infections
Torrance, California, United States
View Trial DetailsNCT02794831
Bacterial Infection, Bacterial Infections
Nantes, France
View Trial Details